Evaluation of Cardiovascular Risk Markers in Hypertensive Pregnant Women
Journal of Advances in Medicine and Medical Research,
Background: In developed countries, heart disease and stroke are the major causes of death. One of the main risk factors of cardiovascular disease is dyslipidemia, and this could be due to increased lipoproteins and/or decreased plasma clearance. Pregnancy is marked with changes in metabolism in preparation for the developing fetus and lactation after delivery. Pregnancy causes long-term metabolic and vascular changes, which may raise the general risk of heart disease.
Aim: The goal of this study was to see how cardiovascular indicators changed during pregnancy in hypertensive pregnant women at Rivers State University Teaching Hospital.
Methodology: The study included 150 people who were divided into three groups: Non-pregnant hypertensive women (50), second trimester pregnant hypertensive women (50), and third trimester pregnant hypertensive women (50). After giving their consent, subjects were chosen using a simple random procedure. Total cholesterol (TC), high density lipoprotein (HDL), triglyceride (TG), low density lipoprotein (LDL), very low density lipoprotein (VLDL), uric acid (UA), C-Reactive protein (CRP), apolipoprotein A1 (APoA1), and apolipoprotein B (APoB) were all measured in the lab using the venipuncture technique under fasting conditions (APoB).
Results: The findings revealed that there was a significant difference in each of the examined parameters (P<0.05) between hypertensive non-pregnant, 2nd trimester, and 3rd trimester hypertensive pregnant women, with the exception of HDL, TG, and VLDL (P>0.05).
Conclusion: This study has shown that hypertensive pregnant women are potential future candidates of cardiovascular disease.
How to Cite
Dashti M, Kulik W, Hoek F, Veerman EC, Peppelenbasch MP, Rezaee F. A phospholipidomic analysis of all defined human plasma lipoproteins. Scientific Reports. 2011;1:139.
Farkas-Epperson M, Le N. Lipoproteins and biosensors of endothelial oxidative status. Clinical Lipidology. 2012;7(1):49-63.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(1):562–569.
Casas JP, Shah T, Hingorani AD, Danesh J, Pepys MB. C-reactive protein and coronary heart disease: A critical review. Journal of Internal Medicine. 2008;264(4):295-314.
Liu Y, Salter HK, Johnson CM, Stephens E, Lakarvsky PJ, Walshaw J, Bullock SL. Bi caudal- D uses a parallel, homodimer coiled coil with heterotypic registry to coordinate recruitment of cargos to dyeing. Genes Development. 2013;27(11):1233-1246.
Mannisto T, Mendola P, Vaarasmaki M, Jarvelin MR, Hartikainen AL, Pouta A. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation. 2013;127(6):681-690.
Biambo KG, Nyebuchi J, Roseline E, Fyneface AC, Laurretta N. Zinc composition in breast milk of lactating mothers in urban and Sub-urban Areas in Rivers State. Asian Journal of Research in Nursing and Health. 2021;4(4):165-169.
Catherine I, Biambo KG, Nyebuchi J, Fyneface AC, Goodnews N. Evaluation of nutrient composition in breast milk of breast feeding mothers in urban and Sub-urban Subjects in Rivers State. Asian Journal of Pediatric Research. 2021;7(2):39-44
Faith D, Kalaotaji GB, Nyebuchi J, Chikadibia FA, Felix EK. Comparative study of heavy metals in breast milk of breast feeding mothers in urban and sub-urban subjects in Rivers state. Journal of Applied Life Sciences International. 2021;28(8):31-36.
Oladapo-Akinfolarin TT, Bartimeaus ES, Nwachukwu EO, Nduka N. Assessment of C-reactive protein levels in normotensive and hypertensive pregnant subjects in Port Harcourt, Nigeria. World Journal of Pharmaceutical and Medical Research. 2017;3(10):292-296.
Oladapo-Akinfolarin TT, Bartimeaus ES, Nwachukwu EO, Nduka N. Assessing lipoprotein levels in normotensive and hypertensive pregnant women in Port Harcourt, Nigeria. American Journal of Biomedical Sciences. 2018;10(1):18- 27.
Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clinical Chemistry. 1972;18:499-502.
Nazir DJ, McQueen MJ. Evaluation of a turbidimetric procedure for Apolipoproteins A1 and B on the CIBA corning 550 express. Clinical Biochemistry. 1993;26(6): 477-482.
Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clinical Chemistry. 1974;20(4):470-475.
Tietz NW. Laboratory methods. In: Fundamentals of Clinical Chemistry, 3rd Edition, W.B. Saunders Company, Philadelphia. 1987;927-962.
Fraser CG, Hearne CR. Assessment of colorimetric enzymatic determination of triglyceride, by manual and centrifugal analyzer techniques, and comparison with a CDC standardized method. Clinical Biochemistry. 1981;14(1):28-31.
Barr WG. Uric acid. In: Walker, H.K., Hall, W.D & Hurst, J.W, editors. Clinical methods: The History, Physical and Laboratory Examinations. 3rd edition, Boston: Butterworths. 1990;16:165.
Raghuram P, Arjun SS, Prakash KK, Babita G, Varshil M, Kunal B, Aadhijaya B. Evaluation of lipid profile in second and third trimester of pregnancy. Journal of Clinical and Diagnostic Research. 2016; 10(3):12-16.
Islam NAF, Chowdhurry MAR, Kibria GM, Akhter S. Study of serum lipid profile in preeclampsia and eclampsia. Faridpur Medical College Journal. 2010;5:56-59.
Charlton F, Tooher J, Rye KA, Hennessy A. A cardiovascular risk, lipids and pregnancy: preeclampsia and the risk of later life cardiovascular disease. Heart Lung Circulation. 2014;23:203- 212.
Shen H, Liu X, Chen Y, He B, Cheng W. Associations of lipid levels during gestation with hypertensive disorders of pregnancy and gestational diabetes mellitus: A prospective longitudinal cohort study. British Medical Journal Open. 2016;6: e013509.
Richard JJ, Mehmet K, Dukhee K, Laura GL, Daniel F. Uric acid: A clinically useful marker to distinguish preeclampsia from gestational hypertension. Hypertension. 2011;58(4):548-549.
Bock JL. Cardiac Injury, Atherosclerosis and thrombotic Disease, In Mcpherson, R.A. & Pincus, M.R. (22nd Edn) Henry’s Clinical Diagnosis and Management by Laboratory Methods (Pp 249-259), Philadelphia, USA: Elservier, Saunders; 2011.
Ernest GDS, de Jonge LL, Hofman A, Lindemans J, Russcher H, Steegers EAP, Jaddoe VWV. C-reactive protein levels in early pregnancy, fetal growth patterns, and the risk for neonatal complications: The Generation R Study. American Journal of Obstetrics and Gynecology. 2011;205(2):132.e1–132.e12.
Abstract View: 135 times
PDF Download: 51 times